BioNTech SE (BNTX)

NASDAQ HEALTHCARE
$108.60 -2.69% RSI 62 Neutral Add Alert

Moving Averages

SMA 200
$103.17
Price above

Company Profile

BioNTech SE, a biotechnology company, develops and markets immunotherapies for cancer and other infectious diseases. The company is headquartered in Mainz, Germany.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$23.26B
P/E Ratio
None
EPS
$-5.49
Beta
1.593
Dividend Yield
0.00%
52-Week High
$124
52-Week Low
$79.52

Similar stocks in BIOTECHNOLOGY

VRTX
Vertex Pharmaceuticals Inc
RSI 40.0
CRSP
CRISPR Therapeutics AG
RSI 41.0
MRNA
Moderna Inc
RSI 46.0
VKTX
Viking Therapeutics Inc
RSI 44.0
SRPT
Sarepta Therapeutics Inc
RSI 48.0
EDIT
Editas Medicine Inc
RSI 50.0

Data last updated: April 10, 2026 at 8:10 AM EDT

Track BNTX for free

Get e-mail RSI alerts when BioNTech SE enters oversold or overbought territory. Free forever.

Add Alert